Eliminating hepatitis C

The Health Care Authority (HCA) is partnering with the Department of Health (DOH) and AbbVie US LLC, a research-based global biopharmaceutical company, in an effort to eliminate hepatitis C (HCV) in Washington State by 2030.

Learn more about eliminating hepatitis C in Washington.

Strategy

HCA, DOH and AbbVie are coordinating efforts to find individuals who are not yet treated; educate the health care workforce about screening and providing curative HCV treatment; and address barriers to care such as stigma, access to HCV providers, and the lack of urgency to treat among patients and providers.

In order to achieve HCV elimination in Washington State, DOH convened partners and stakeholders to develop the Hep C Free Washington plan. These include:

  • People affected by HCV
  • Local health jurisdictions
  • Tribal Nations
  • Medical providers
  • Others with an interest in HCV elimination

What we need from providers

Action! This is a huge opportunity to rid our state of the most common blood borne disease in the United States – and now it is possible.

Effective immediately, we would like all providers licensed to treat HCV to screen and treat the target population. In order to support our provider community in this monumental effort, Apple Health (Medicaid) has made important policy changes:

  • The antiviral Mavyret™ no longer requires prior authorization (PA). Other direct-acting antivirals will require review and will be approved only when Mavyret™ is not clinically appropriate.
  • Anyone licensed to prescribe direct acting antiviral medications is allowed to screen and treat Apple Health members to support this effort.

Webinars and virtual learnings/updates

HCA has launched a webinar series dedicated to highlighting efforts to eliminate HCV in Washington State.

Time and date (Pacific) Registration Agenda

November 6, 2020

Listen at your convenience

HCA webinar series recording:
Myth busting: treating hepatitis C in primary care

Presenter: John Scott, MD, MSc

  • Disease state
  • Treatment review and myth busting
  • Care models including treating patients in the telemedicine environment

October 6, 2020

Listen at your convenience

HCA webinar series recording:
Eliminating hepatitis C in Washington State

  • Hepatitis C in Washington State
  • Governor Inslee’s 2018 Directive 18-13
  • Department of Health (DOH) and Hep C Free Washington
  • The role of Primary Care Providers (PCPs)
  • What’s to come in future webinars
  • Questions and closing

Elimination awareness bus

HCA and AbbVie deployed an HCV elimination awareness bus to areas of Washington State with high-risk HCV populations. This strategy is part of a national program to educate the population about the importance of screening and linkage to care. When a person visits the bus, they are able to get hep C antibody testing to determine if they may have the virus.

2022 bus stops

Date

Event

Event details

October 8 Family Medical Health Fair

Time: 10 a.m. – 2 p.m.

Location: 1120 West Rose Street Walla Walla, WA 99362

October 7 Project Homeless Connect

Time: 11 a.m. – 3 p.m.

Location: The Church Jesus Christ of Latter Day Saints, 1102 South Pearl St, Tacoma, WA 98465

 

Resources